Scott S Zamvil Selected Research

Scott S Zamvil Research Topics

Disease

68	Multiple Sclerosis 04/2022 - 09/2002
40	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 09/2002
15	Autoimmune Diseases (Autoimmune Disease) 11/2020 - 11/2002
13	Neuromyelitis Optica (Devic's Disease) 01/2020 - 11/2010
11	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 11/2002
9	Paralysis (Palsy) 05/2017 - 11/2002
8	Inflammation (Inflammations) 01/2021 - 04/2006
7	Relapsing-Remitting Multiple Sclerosis 01/2019 - 09/2002
6	Neuroinflammatory Diseases 04/2019 - 06/2003
5	COVID-19 01/2022 - 01/2020
5	Disease Progression 10/2016 - 09/2002
4	Infections 10/2021 - 09/2003
4	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2018 - 06/2003
3	Central Nervous System Diseases (CNS Diseases) 12/2019 - 06/2003
3	Neoplasms (Cancer) 01/2018 - 01/2008
3	Progressive Multifocal Leukoencephalopathy 08/2010 - 12/2008
2	Atrophy 11/2019 - 05/2012
2	Alzheimer Disease (Alzheimer's Disease) 11/2018 - 06/2003
2	Chronic Progressive Multiple Sclerosis 01/2016 - 06/2004
2	Encephalomyelitis (Myeloencephalitis) 09/2015 - 09/2002
2	Atherosclerosis 09/2006 - 12/2005
1	Hot Flashes 05/2022
1	Thrombosis (Thrombus) 10/2021
1	Thromboinflammation 10/2021
1	Vasculitis (Vasculitides) 10/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2020
1	Glioma (Gliomas) 01/2020

Drug/Important Bio-Agent (IBA)

14	Glatiramer Acetate (Copaxone)FDA Link 01/2020 - 09/2002
12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2011 - 11/2002
11	AntibodiesIBA 01/2021 - 12/2004
9	AutoantigensIBA 01/2020 - 08/2007
7	CytokinesIBA 01/2020 - 11/2002
7	Natalizumab (Tysabri)FDA Link 01/2019 - 07/2006
7	Pharmaceutical PreparationsIBA 12/2014 - 06/2004
6	Immunoglobulin G (IgG)IBA 11/2021 - 11/2010
5	AutoantibodiesIBA 10/2021 - 11/2010
5	Proteins (Proteins, Gene)FDA Link 10/2021 - 12/2004
5	Aquaporins (Water Channels)IBA 01/2018 - 11/2010
5	Myelin-Oligodendrocyte GlycoproteinIBA 10/2016 - 05/2011
5	Peptides (Polypeptides)IBA 04/2016 - 12/2004
4	EpitopesIBA 10/2021 - 05/2017
4	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 07/2012
4	InterferonsIBA 01/2020 - 11/2002
4	laquinimodIBA 10/2016 - 01/2012
4	Interferon-betaIBA 01/2005 - 09/2002
3	Monoclonal AntibodiesIBA 10/2021 - 08/2010
3	AntigensIBA 01/2020 - 08/2007
3	Atorvastatin (Lipitor)FDA Link 02/2014 - 11/2002
3	Immunosuppressive Agents (Immunosuppressants)IBA 02/2011 - 06/2004
3	Biological ProductsIBA 10/2008 - 05/2006
3	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2006 - 06/2004
2	Messenger RNA (mRNA)IBA 04/2022 - 11/2021
2	COVID-19 VaccinesIBA 01/2022 - 09/2021
2	Fibrinogen (Factor I)FDA Link 10/2021 - 09/2015
2	FibrinIBA 10/2021 - 11/2018
2	Alemtuzumab (Campath)FDA Link 11/2020 - 10/2020
2	Rituximab (Mabthera)FDA Link 11/2020 - 08/2009
2	Therapeutic UsesIBA 01/2020 - 08/2007
2	ChemokinesIBA 01/2020 - 09/2015
2	Oligoclonal BandsIBA 01/2020 - 12/2016
2	Cholecalciferol (Vitamin D3)FDA Link 12/2019 - 01/2019
2	Retinaldehyde (Retinal)IBA 11/2019 - 01/2017
2	Interleukin-10 (Interleukin 10)IBA 04/2019 - 01/2019
2	Immunoglobulin A (IgA)IBA 04/2019 - 01/2019
2	Amino Acids FDA Link 01/2019 - 08/2014
2	ocrelizumabIBA 01/2018 - 01/2016
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 12/2016 - 08/2014
2	EnzymesIBA 12/2016 - 02/2006
2	Biomarkers (Surrogate Marker)IBA 09/2016 - 07/2013
2	Dimethyl FumarateIBA 04/2016 - 06/2015
2	Integrin alpha4beta1 (VLA-4)IBA 04/2016 - 05/2015
2	peptide PIBA 08/2014 - 05/2013
2	Immunomodulating AgentsIBA 02/2011 - 06/2004
2	Neutralizing AntibodiesIBA 11/2007 - 12/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2007 - 11/2002
2	Interleukin-12 (IL 12)IBA 08/2007 - 11/2002
2	Simvastatin (Zocor)FDA LinkGeneric 01/2007 - 01/2005
2	Coenzyme A (CoA)IBA 09/2006 - 12/2005
2	Oxidoreductases (Dehydrogenase)IBA 09/2006 - 12/2005
2	CholesterolIBA 09/2006 - 05/2006
1	Hormones (Hormone)IBA 05/2022
1	BNT162 VaccineIBA 04/2022
1	VaccinesIBA 11/2021
1	Indicators and Reagents (Reagents)IBA 11/2021
1	SARS-CoV-2 spike proteinIBA 10/2021
1	Blood Coagulation Factors (Coagulation Factor)IBA 10/2021
1	B-Cell Maturation AntigenIBA 01/2021
1	TACI receptor-IgG Fc fragment fusion proteinIBA 01/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2021
1	ozanimodIBA 01/2020
1	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 01/2020
1	acivicin (AT 125)IBA 01/2020
1	Ataxin-1IBA 01/2020
1	Leucovorin (Folinic Acid)FDA Link 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	Glutathione (Reduced Glutathione)IBA 01/2020

Therapy/Procedure

36	Therapeutics 05/2022 - 09/2002
4	Immunotherapy 01/2022 - 11/2018
2	Drug Therapy (Chemotherapy) 11/2010 - 09/2002